This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Miyarisan Pharmaceutical Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Kaori Ohtani: Innovator in Peptide Research
Introduction
Kaori Ohtani is a prominent inventor based in Kanazawa, Japan. She has made significant contributions to the field of peptide research, particularly in the development of solutions for health issues caused by harmful bacteria.
Latest Patents
Ohtani holds a patent for a peptide that inhibits the production of toxins by bacteria belonging to the genus Clostridium. This innovation aims to provide a means for preventing, treating, and controlling health damages, including food poisoning and infections. The cyclic peptide she developed contains the sequence Cys-Phe-Trp-Ala-His, which is crucial for its effectiveness.
Career Highlights
Throughout her career, Ohtani has focused on advancing medical research and developing practical applications for her findings. Her work has the potential to significantly impact public health by addressing issues related to bacterial infections.
Collaborations
Ohtani has collaborated with notable colleagues, including Tohru Shimizu and Jiro Nakayama, to further her research and enhance the effectiveness of her innovations.
Conclusion
Kaori Ohtani's contributions to peptide research exemplify her commitment to improving health outcomes through innovative solutions. Her work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile